COVID-19 and Sodium-Glucose Cotransporter 2 Inhibitors: No Fear to Attempt?
Exp Clin Endocrinol Diabetes DOI: 10.1055/a-1235-5617Novel coronavirus infectious disease (COVID-19) has been recognised as a pandemic by
the World Health Organization (WHO) 1.
Mortality and morbidity are higher in elderly individuals and those with
comorbidities, such as diabetes mellitus (DM), obesity, hypertension, respiratory
tract diseases, coronary heart disease or cancer 1. Indeed, two thirds of individuals who
died from COVID-19 had DM in Italy 2. [...] © Georg Thieme Verlag KG Stuttgart · New YorkArticle in Thieme eJournals: Table of contents | Abstract | Full text
Source: Experimental and Clinical Endocrinology and Diabetes - Category: Endocrinology Authors: Papachristou, Stella Penlioglou, Theano Stoian, Anca Pantea Papanas, Nikolaos Tags: Commentary Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Coronary Heart Disease | Coronavirus | COVID-19 | Diabetes | Diabetes Mellitus | Eating Disorders & Weight Management | Endocrinology | Heart | Heart Disease | Hypertension | Infectious Diseases | International Medicine & Public Health | Italy Health | Obesity | Pandemics | Respiratory Medicine | Sodium | WHO